Index Venture Life Associates VI Ltd

In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Index Venture Life Associates VI Ltd reported 2 stock positions worth $167.1 million. Its top holding was Centessa Pharmaceuticals (CNTA) at 99.9% of the portfolio, followed by Century Therapeutics (IPSC, 0.1%).

Most Recent 13F
Q2 2026
Location
ST. HELIER, Y9
CIK
0001865139
Portfolio Value
$167.1M (Q4 2024)
SEC Filing
0000950123-25-002732 ↗ filed Feb 14, 2025

Holdings Value

0$100.0M$200.0M$300.0M$400.0M Q4 2024: $167.1M $167.1M Q4 2024 Q1 2025: $143.3M Q1 2025 Q2 2025: $130.9M Q2 2025 Q3 2025: $241.6M Q3 2025 Q4 2025: $249.1M Q4 2025 Q1 2026: $395.7M Q1 2026 Q2 2026: $0 Q2 2026

Holdings 2 stocks · $167.1M
CNTA Centessa Pharmaceuticals Ltd. 99.89% 9,961,789 $166.9M —
IPSC Century Therapeutics Inc. 0.11% 188,251 $190K —

Portfolio Sells Q4 2024

No earlier filing to compare with.

Portfolio Buys Q4 2024

No earlier filing to compare with.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 0$0
Q1 2026 1$395.7MCNTA
Q4 2025 1$249.1MCNTA
Q3 2025 1$241.6MCNTA
Q2 2025 1$130.9MCNTA
Q1 2025 1$143.3MCNTA
Q4 2024 2$167.1MCNTA, IPSC